SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is surging as market participants react to headlines regarding potential diplomatic negotiations to end the ongoing conflict in the Middle East, despite ongoing volatility in oil prices. The community remains deeply divided, with many debating whether the rally is a genuine recovery or a temporary relief pop driven by unverified news and algorithmic positioning.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The market is experiencing a high-volatility relief rally driven by conflicting headlines regarding potential war de-escalation in the Middle East and end-of-quarter portfolio rebalancing. While many traders are skeptical and labeling the move a bull trap, the community remains deeply divided, with bears pointing to elevated oil prices as a sign of underlying fragility while bulls are aggressively buying the dip on expectations of institutional support.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community buzz as investors brace for the late-breaking presentation of 40-week VELA trial data at the upcoming American Academy of Dermatology annual meeting. The stock is seeing significant institutional accumulation and analyst upgrades, with shareholders actively debating the potential for a transformative buyout as the company solidifies its position as a best-in-class leader in the hidradenitis suppurativa treatment landscape.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors gear up for the upcoming release of the company's 2025 Annual Report and earnings call, which are being closely watched for signs of a turnaround. The community is actively debating the stock's potential for a squeeze, citing high short interest and a significant valuation gap compared to its underlying assets, while tracking the company's recent debt reduction efforts.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is facing intense volatility as market participants debate the company's aggressive dilution strategy for Bitcoin accumulation amidst broader macroeconomic concerns and recent quantum computing headlines. The community remains deeply polarized, with bulls highlighting the potential of Saylor's treasury model while bears increasingly warn of sustainability risks, dividend pressures, and potential downside price targets.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trading higher as the market weighs escalating conflict in the Middle East and the uncertainty surrounding the Strait of Hormuz against mixed signals from U.S. leadership regarding peace negotiations. The community is sharply divided, with many traders betting on further supply shocks and potential price surges, while others view current levels as an overextended rally susceptible to sudden corrections.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around its long-standing presence in the market and maintains a high-energy, humorous social media campaign. Investors are actively discussing the token's mass-adoption goals while utilizing the project's decentralized swap options to grow their holdings.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The biotech sector is experiencing significant volatility and renewed investor interest, driven by a wave of high-premium M&A activity and positive data readouts for late-stage pipeline assets. While broader market uncertainty and geopolitical concerns have created a tug-of-war in price action, the community remains intensely focused on identifying potential buyout targets and monitoring institutional accumulation patterns within small-cap biotech leaders.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is seeing intense retail activity as traders speculate on a potential short squeeze fueled by an exceptionally tight public float and high borrow rates. The community remains deeply divided, with bulls betting on explosive price volatility similar to past market runners, while bears warn of a pump-and-dump scheme driven by lack of institutional support and low trading volumes.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for the treatment of rare kidney diseases, C3G and primary IC-MPGN. Investors are actively discussing the potential impact of this label expansion on long-term revenue growth and its role in bolstering the company's position as a buyout candidate, while monitoring how this news might trigger a short squeeze given the stock's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets

Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets PR Newswire...

Axcelis Technologies (ACLS) Stock Moves -1.02%: What You Should Know

Axcelis Technologies (ACLS) closed the most recent trading day at $97.35, moving 1.02% from the previous trading session.

Axcelis Technologies Reaches Analyst Target Price

In recent trading, shares of Axcelis Technologies Inc (Symbol: ACLS) have crossed above the average analyst 12-month target price of $95.25, changing hands for $100.85/share. When a stock reaches the...

Axcelis Technologies (NASDAQ:ACLS) Trading Up 10.2%  - Should You Buy?

Axcelis Technologies (NASDAQ:ACLS) Shares Up 10.2% - Should You Buy...

Oliver Luxxe Assets LLC Invests $1.45 Million in Axcelis Technologies, Inc. $ACLS

Oliver Luxxe Assets LLC purchased a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 18,063 shares of the semiconductor company's stock...

Axcelis Technologies (ACLS) Gains As Market Dips: What You Should Know

In the latest trading session, Axcelis Technologies (ACLS) closed at $87.12, marking a +1.61% move from the previous day.

Axcelis Announces Participation in SEMICON China 2026

Axcelis Announces Participation in SEMICON China 2026 Axcelis Announces Participation in SEMICON China 2026 PR Newswire BEVERLY, Mass., March 19, 2026 President and CEO Russell Low will Present...

Axcelis Technologies, Inc. (NASDAQ:ACLS) Receives Consensus Rating of "Hold" from Analysts

Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) has received an average recommendation of "Hold" from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have assign...

Axcelis Technologies, Inc. $ACLS Stake Lessened by Mizuho Markets Cayman LP

Mizuho Markets Cayman LP cut its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 63.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

Axcelis Technologies, Inc. (NASDAQ:ACLS) Short Interest Down 25.9% in February

Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 3,698,624 shares...

Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.

Axcelis Technologies Inc

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

Current Price	$93.05
Prev Close	$90.43
Open	$92.15
Dividend Yield	0.00%
50-Day Moving Average	$87.63
Beta	1.96
Avg. Volume	1.14M
PE Ratio	23.82

52-Week High	$102.93
52-Week Low	$40.40
Market Capitalization	$2.78B
EPS (Annual)	$3.80
Price to Book	2.68
Revenue Per Employee	$572,729.01

ACLS
Axcelis Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACLS News

ACLSAxcelis Technologies Inc